Form 4: Arcutis Biotherapeutics Executive Sells Shares to Cover Tax Obligations

Larry Todd Edwards, EVP Chief Commercial Officer at Arcutis Biotherapeutics, sold shares to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• On May 19, 2025, Larry Todd Edwards, EVP Chief Commercial Officer of Arcutis Biotherapeutics, sold 7,451 shares of common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs) granted on February 22, 2024.
• The shares were sold at a weighted average price of $14.0719, with individual transactions ranging from $13.6763 to $14.49.
• Following the transaction, Edwards directly owns 183,104 shares of Arcutis Biotherapeutics.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale for tax obligations) and doesn't convey any strong positive or negative sentiment about the company's prospects.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies, often related to compensation and tax planning. The sale itself doesn't necessarily indicate a negative outlook for the company.

Stakeholder Impact

• The stock sale may have a minor, temporary impact on the stock price, but is unlikely to significantly affect long-term shareholders.

Key Dates

Keywords

Arcutis Biotherapeutics, ARQT, Larry Todd Edwards, Form 4, Executive Stock Sale, Restricted Stock Units, Tax Withholding